OUTCOME AND RISK FACTORS FOR MORTALITY IN PEDIATRIC PERITONEAL DIALYSIS

被引:22
作者
Tsai, Hsin-Lin [2 ,3 ]
Yang, Ling-Yu [1 ,3 ]
Chin, Tai-Wai [2 ,3 ]
Wang, Hsin-Hui [1 ,3 ]
Liu, Chin-Su [2 ,3 ]
Wei, Chou-Fu [2 ,3 ]
Chang, Jei-Wen [1 ,3 ]
机构
[1] Taipei Vet Gen Hosp, Dept Pediat, Taipei 11217, Taiwan
[2] Taipei Vet Gen Hosp, Div Pediat Surg, Dept Surg, Taipei 11217, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2010年 / 30卷 / 02期
关键词
Hypoalbuminemia; mortality; outcome; pediatrics; risk factor; STAGE RENAL-DISEASE; CAPD PATIENTS; HEMODIALYSIS-PATIENTS; EQUILIBRATION TEST; TECHNIQUE FAILURE; PREDICTIVE VALUE; PROTEIN LOSSES; SERUM-ALBUMIN; DEATH RISK; CHILDREN;
D O I
10.3747/pdi.2008.00278
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The mortality rate among children requiring renal replacement therapy is higher than in children without end-stage renal disease (ESRD). Some factors, such as hypoalbuminemia, high peritoneal transport rate, age, malnutrition, cardiovascular disease, and recurrent peritonitis, appear to be associated with lower survival in adult peritoneal dialysis patients. Data regarding risk factors of mortality in children with continuous ambulatory peritoneal dialysis (CAPD) are limited. The aims of this study were to analyze the clinical characteristics of patients and investigate if routinely used laboratory and clinical variables are independent risk factors for mortality in children on CAPD. Methods: We performed a retrospective chart analysis of pediatric ESRD patients on CAPD between January 1997 and September 2008. 29 patients undergoing CAPD for more than 3 months were enrolled. An analysis was performed on clinical and biochemical variables for survivors and nonsurvivors to identify potential risk factors for mortality. Results: Mean age was 12.18 +/- 4.57 years. During the follow-up period, 8 patients transferred to hemodialysis and 13 patients received deceased donor renal transplantation. By the end of the study, 5 patients had died. Actuarial survival rate at 2 and 5 years was 96.55% and 91.19% respectively. The major complication during therapy was peritonitis (1 episode/57.79 patient-months). In the univariate analysis, younger age at initiation of dialysis, presence of comorbid disease, higher peritoneal transport rate, increased protein losses through peritoneal dialysis, high total daily protein loss, hypoalbuminemia, and hypophosphatemia were variables associated with mortality in pediatric CAPD patients. However, in the multivariate analysis, only low serum albumin (b = - 2.089, p = 0.006; hazard ratio 8.06, 95% confidence interval 0.028 - 0.546) was independently associated with mortality. Conclusion: Mortality was low in our pediatric patients receiving CAPD. Hypoalbuminemia showed a significant association with death in CAPD patients.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 50 条
[1]  
Avram M M, 1996, Perit Dial Int, V16 Suppl 1, pS190
[2]   PREDICTORS OF SURVIVAL IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS - THE IMPORTANCE OF PREALBUMIN AND OTHER NUTRITIONAL AND METABOLIC MARKERS [J].
AVRAM, MM ;
GOLDWASSER, P ;
ERROA, M ;
FEIN, PA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (01) :91-98
[3]  
BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329
[4]  
BLAKE PG, 1993, J AM SOC NEPHROL, V3, P1501
[5]   PROTEIN LOSSES DURING PERITONEAL-DIALYSIS [J].
BLUMENKRANTZ, MJ ;
GAHL, GM ;
KOPPLE, JD ;
KAMDAR, AV ;
JONES, MR ;
KESSEL, M ;
COBURN, JW .
KIDNEY INTERNATIONAL, 1981, 19 (04) :593-602
[6]   Prevalence of protein malnutrition in children maintained on peritoneal dialysis [J].
Brem, AS ;
Lambert, C ;
Hill, C ;
Kitsen, J ;
Shemin, DG .
PEDIATRIC NEPHROLOGY, 2002, 17 (07) :527-530
[7]   Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis [J].
Brimble, K. Scott ;
Walker, Michelle ;
Margetts, Peter J. ;
Kundhal, Kiran K. ;
Rabbatt, Christian G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2591-2598
[8]   Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: A North American Pediatric Renal Trials and Collaborative Studies special analysis [J].
Carey, William A. ;
Talley, Lynya I. ;
Sehring, Sally A. ;
Jaskula, Janet M. ;
Mathias, Robert S. .
PEDIATRICS, 2007, 119 (02) :E468-E473
[9]  
Chung SH, 2000, PERITON DIALYSIS INT, V20, P541
[10]  
Churchill DN, 1996, J AM SOC NEPHROL, V7, P198